摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 4-phenylpyridine-3-carboxylate | 40541-76-2

中文名称
——
中文别名
——
英文名称
Ethyl 4-phenylpyridine-3-carboxylate
英文别名
4-phenylnicotinic acid ethyl ether;ethyl 4-phenylnicotinate;4-phenyl-nicotinic acid ethyl ester;3-Pyridinecarboxylic acid, 4-phenyl-, ethyl ester
Ethyl 4-phenylpyridine-3-carboxylate化学式
CAS
40541-76-2
化学式
C14H13NO2
mdl
——
分子量
227.263
InChiKey
SFGNKGXOZFYBEE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    356.5±30.0 °C(Predicted)
  • 密度:
    1.123±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    39.2
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Ethyl 4-phenylpyridine-3-carboxylate2,2,6,6-四甲基哌啶氧化物碘苯二乙酸三乙酰氧基硼氢化钠二异丁基氢化铝N,N-二异丙基乙胺 、 Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-) 作用下, 以 二氯甲烷甲苯乙腈 为溶剂, 反应 1.5h, 生成 N-(3,5-bis(trifluoromethyl)benzyl)-N-((4-phenylpyridin-3-yl)methyl)cyclohexanecarboxamide
    参考文献:
    名称:
    Design, synthesis and biological evaluation of a novel class of potent TGR5 agonists based on a 4-phenyl pyridine scaffold
    摘要:
    TGR5, a GPCR, is involved in energy and glucose homeostasis, and as such, is a target for the treatment of diabetes, obesity and other metabolic syndromes. A new class of TGR5 agonists based on a 4-phenyl pyridine scaffold was designed, synthesized and evaluated in vitro and in vivo. Extensive structure activity relationship studies are reported herein. The most potent compounds 15a, 18b and 18c showed comparable activity with the lead compound 2. 15a had the best potency in vitro but displayed an pharmacokinetic profile and was found to be ineffective during an oral glucose tolerance test in imprinting control region mice at a dose of 50 mg/kg. (C) 2013 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2013.07.050
  • 作为产物:
    描述:
    烟酸乙酯copper(l) iodide 作用下, 以 四氢呋喃 为溶剂, 反应 672000.67h, 生成 Ethyl 4-phenylpyridine-3-carboxylate
    参考文献:
    名称:
    First Rotameric Anti Dimers and 3,9-Diazatetraasteranes from Unsymmetrically Substituted N-Acyl and N-Acyloxy-4-aryl-1,4-dihydropyridines
    摘要:
    A series of unsymmetrically substituted N-acyl- and N-acyloxy-1,4-dihydropyridines (1) have been photochemically investigated. On irradiating the crystals of one derivative (la) containing centrosymmetrical pairs of molecules with a distance of 3.894(3) Angstrom between the potentially reacting double bonds favorable for a photodimerisation reaction, the formation of an anti-dimer (2a) was observed. Two other solid derivatives (1b, c) merely decomposed on irradiation to give substituted pyridine compound (3). Solution irradiation of 1,4-dihydropyridines (1) led to the centrosymmetric cage compounds 3,9-diazatetraasteranes (4) and to anti dimers (2) as main products, both existing as rotamers. Symmetric as well as rotameric properties of selected compounds (4) have been demonstrated by X-Ray crystal structure analysis and H-1 NMR spectroscopy.
    DOI:
    10.3987/com-01-9423
点击查看最新优质反应信息

文献信息

  • Design, Synthesis, and Structure-Activity Relationships of 3,4,5-Trisubstituted 4,5-Dihydro-1,2,4-oxadiazoles as TGR5 Agonists
    作者:Junjie Zhu、Yangliang Ye、Mengmeng Ning、Attila Mándi、Ying Feng、Qingan Zou、Tibor Kurtán、Ying Leng、Jianhua Shen
    DOI:10.1002/cmdc.201300144
    日期:2013.7
    By thorough analysis of diverse structures of published TGR5 agonists, a hypothetical ligand‐based pharmacophore model was built, and a new class of potent TGR5 agonists, based on the novel 3,4,5trisubstituted 4,5‐dihydro‐1,2,4‐oxadiazole core, was discovered by rational design. Three distinct synthetic methods for constructing 4,5‐dihydro‐1,2,4‐oxadiazoles and extensive structure–activity relationship
    鉴于其在能量和葡萄糖稳态中的介导作用,G蛋白偶联胆汁酸受体1(TGR5)被认为是治疗2型糖尿病和其他代谢性疾病的潜在靶标。通过对已发表的TGR5激动剂的各种结构进行全面分析,建立了一个假设的基于配体的药效团模型,并基于新型3,4,5-三取代的4,5-二氢-1,2来开发了一类新型的强效TGR5激动剂。 ,4-恶二唑核是通过合理设计发现的。本文报道了三种不同的合成方法来构建4,5-二氢-1,2,4-恶二唑和广泛的结构-活性关系研究。化合物(R)-54 n,其结构是通过单晶X-射线衍射和量子化学固态TDDFT-ECD计算确定,显示出最好的效力,用EC 50为1.4的n值中号朝向hTGR5。它在体外的有利特性值得进一步研究。
  • Observations on the DDQ Oxidation of 1-Acyldihydropyridines - A Synthetic Application
    作者:Debra J. Wallace、Andrew D. Gibb、Ian F. Cottrell、Derek J. Kennedy、Karel M. J. Brands、Ulf H. Dolling
    DOI:10.1055/s-2001-17509
    日期:——
    A synthetic application of the rate difference in oxidation of regioisomerically substituted N-acyldihydropyridines is reported. This has allowed for isolation of pure 4-substituted pyridine isomers without the need for chromatography. Diels-Alder adducts between a dihydropyridine and DDQ were isolated and formation of novel hydroquinone ethers was also observed during some reactions.
    报道了区域异构取代的N-酰基二氢吡啶氧化速率差异的综合应用。这一方法使得无需色谱分离即可获得纯的4-取代吡啶异构体。在某些反应中,二氢吡啶与DDQ的Diels-Alder加合物被分离出来,并且观察到了新型的氢醌醚的形成。
  • Regioselective addition of organomagnesium reagents to N-silyl activated nicotinic acid esters—a convenient method for the synthesis of 4,4-disubstituted 1,4-dihydronicotinates
    作者:Christian A. Sperger、Klaus T. Wanner
    DOI:10.1016/j.tet.2009.05.008
    日期:2009.7
    The addition of RMgX or R2Mg to nicotinic acid esters, activated with triisopropylsilyl triflate, was investigated. The regioselectivity of this reaction, where 4-unsubstituted and 4-substituted pyridine derivatives were employed as starting materials, was examined. Depending on the structure of the organomagnesium reagent varying ratios of 1,2-, 1,4-, and 1,6-regioisomers were obtained but in any
    研究了将RMgX或R 2 Mg添加到被三氟甲磺酸三异丙基甲硅烷基酯活化的烟酸酯中。检查了该反应的区域选择性,其中使用4-未取代的和4-取代的吡啶衍生物作为起始原料。取决于有机镁试剂的结构,获得了1,2-,1,4-和1,6-区域异构体的不同比率,但是在任何情况下1,4-加成产物显然都是主要的。异构体纯加成产物与LiOH的甲硅烷基化可提供稳定的4,4-二取代的二氢吡啶,这些化合物很容易用卤代烷以高收率进行N-烷基化。此外,显示出所获得的二氢吡啶的甲硅烷基保护基可以容易地被酰基取代。
  • Aza-Wittig reaction of N-vinylic phosphazenes with carbonyl compounds. Azadiene-mediated synthesis of dihydropyridines and pyridines
    作者:Francisco Palacios、Gloria Rubiales
    DOI:10.1016/0040-4039(96)01352-4
    日期:1996.8
    diphenylmethylphosphine 4 with carbonyl compounds leads to the formation of 2-azadienes derived from β-aminoacids 5. Dimerization of 2-azadienes 5c,d and reaction of compounds 5 with phosphazene 4 or enemine 6 affords substituted dihydropyridines 7 and 8. Aza-Wittig reaction of phosphazenes 4 with α,β-unsaturated aldehydes gives 3-azatrienes 12, which are easily converted into pyridines 13.
    衍生自二苯基甲基膦4的N-乙烯基磷腈与羰基化合物的Aza-Wittig反应导致衍生自β-氨基酸5的2-氮杂二烯形成。2-氮杂二烯5c,d的二聚和化合物5与磷腈4或亚胺6的反应,得到取代的二氢吡啶7和8。磷腈4与α,β-不饱和醛的Aza-Wittig反应产生3-氮杂三酮12,该氮杂三氮烯12易于转化为吡啶13。
  • Identification and Characterization of m1 Selective Muscarinic Receptor Antagonists
    作者:Corinne E. Augelli-Szafran、C. John Blankley、Juan C. Jaen、David W. Moreland、Carrie B. Nelson、Jan R. Penvose-Yi、Roy D. Schwarz、Anthony J. Thomas
    DOI:10.1021/jm980067l
    日期:1999.2.1
    A series of esters of 1,4-disubstituted tetrahydropyridine carboxylic acids (I) has been synthesized and characterized as potential mi selective muscarinic receptor antagonists. The affinity of these compounds for the five human muscarinic receptor subtypes (Hm1-Hm5) was determined by the displacement of [H-3]-NMS binding using membranes from transfected Chinese hamster ovarian cells. One of the most potent and selective compounds of this series is an analogue of I [11, R-1 = (CH2)(5)CH3], which has an IC50 value of 27.3 nM at the m1 receptor and possesses 100-fold (m2), 48-fold (m3), 74-fold (m4), and 19-fold (m5) selectivities at the other receptors. Thus, this analogue appears to be more selective on the basis of binding than the prototypical mi antagonist, pirenzepine. Functional data, such as the inhibition of carbachol-stimulated phosphatidylinositol hydrolysis, on selected analogues confirmed the muscarinic antagonistic properties of this chemical series.
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-